We collaborate with academic, patient and industry groups to quickly progress new rare disease treatments through the clinic and towards patients
Ways of working together
True medical breakthroughs happen when industry, patient groups and academic institutions work together. And whilst cutting-edge AI technology is integral to our work, we recognise that without the involvement of our partners we couldn’t have achieved as much as we have done to date.
We welcome enquiries from groups working on rare conditions where relevant assets, resources and data are available. If you are interested in partnering with us to progress treatments for your disease of interest please get in touch.
Rare Treatment Accelerator
The Rare Treatment Accelerator is our global partnering programme designed to unlock the power of repurposed drugs for rare diseases.
Working together with research institutions, patient organisations and early-stage biotechs we can quickly turn your research, insights and promising repurposing therapies into novel treatments.
Please take a look at our Rare Treatment Accelerator web page for more information on eligibility criteria and our collaboration process. For all other questions, please email our team at firstname.lastname@example.org